Home » Topics » Regulatory » Patents

Patents
RSS

Novel PD-1/PD-L1 interaction inhibitors derived at Polaris Pharmaceuticals

March 23, 2018

Roche describes new TLR7 agonists and HBsAg secretion inhibitors

March 23, 2018

Zhejiang Hisun Pharmaceutical identifies new anti-HBV compounds

March 23, 2018

Merck & Co. identifies novel IDO-1 inhibitors

March 23, 2018

GlaxoSmithKline divulges novel bromodomain and extra-terminal protein inhibitors

March 22, 2018

Technical University of Denmark presents ROS-activated methotrexate and aminopterin prodrugs

March 22, 2018

Genentech and Roche present new HsNIK inhibitors

March 22, 2018

Novel serine protease HTRA1 inhibitors identified at Roche

March 22, 2018

Eli Lilly discovers novel PDE1 inhibitors

March 22, 2018

Idenix Pharmaceuticals, Merck & Co. patent novel tenofovir prodrugs

March 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...